Q-omics provides the consensus-scored RN7SL431P profile across patient tissues and cancer cell-line models. RN7SL431P expression is associated with patient survival in 20 of 34 cancer types, with the highest sampling consensus in UVM. Among the 18 cancer types available for tumor–normal comparison, RN7SL431P is differentially expressed in 8, with the highest sampling consensus in HNSC. Additionally, RN7SL431P RNA expression shows 17,235 significant gene co-expression associations, with the highest sampling consensus in UVM. Together, these results highlight UVM, and HNSC as cancer lineages where RN7SL431P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for RN7SL431P — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes RN7SL431P survival associations across molecular data types. RN7SL431P RNA expression shows survival associations in the most cancer types (20). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible RN7SL431P RNA expression–survival associations across cancer types. High RN7SL431P expression shows unfavorable associations in UVM, LUSC and PCPG, but favorable associations in UCS, READ and BRCA. The UVM Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .001). Together, the overview and detailed table identify UVM as the clearest survival context for RN7SL431P RNA expression.
This table summarizes RN7SL431P tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 8. The strongest signals are observed in HNSC for RNA.
This table ranks reproducible tumor–normal expression differences for RN7SL431P. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. RN7SL431P shows lower tumor expression in HNSC, LUSC and KICH and higher tumor expression in CHOL, KIRC and COAD. The HNSC box plot shows higher RN7SL431P RNA expression in normal versus tumor tissue (log2 FC = −1.827, t-test p = .001).
This table shows molecular features associated with RN7SL431P in patient tissues and cancer cell lines. In patient samples, RN7SL431P shows the broadest associations at the RNA and protein expression levels, with UVM recurring as the lineage with the largest associated feature set.
